Cancer Market Research Reports

RSS Sort By :
TITLE Price Buy Now More options

Cervical cancer diagnostic tests are used to identify the presence of the precancerous or cancerous lesions in the cervix of a woman. These tests include an initial screening using pap smear and HPV testing, and upon positive results, colposcopy a...

$ 2500


Breath analyzers are devices used to detect the presence of different compounds in the breath sample of individuals. They are most commonly used to measure blood alcohol content levels (BAC). These devices play a significant role in the conviction...

$ 4650


Colorectal cancer (CRC) is cancer that starts in the colon or the rectum. CRC has the third highest incidence among all cancers in men and second highest in women. CRC is a high mortality cancer, with mortality rates just behind lung, liver, and s...

$ 3995


The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in cancer vaccine partnering deal...

$ 1995


The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in cancer diagnostics par...

$ 2995


Global Markets Direct's, ‘Metastatic Breast Cancer Pipeline Review, H2 2014', provides an overview of the Metastatic Breast Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic developm...

$ 2000


Global Markets Direct's, ‘Esophageal Cancer Pipeline Review, H2 2014', provides an overview of the Esophageal Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Esopha...

$ 2000


Global Markets Direct's, ‘Thyroid Cancer Pipeline Review, H2 2014', provides an overview of the Thyroid Cancer's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Thyroid Canc...

$ 2000


GlobalData has released its new PharmaPoint Drug Evaluation report, Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the worl...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the w...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, MGN1703 (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world an...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the worl...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Nintedanib (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the wo...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world...

$ 3495


GlobalData has released its new PharmaPoint Drug Evaluation report, Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world...

$ 3495


Cancer occurs when, after undergoing cell transformation, normal cells grow and multiply without control. Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Non-small cell lung cancer is the common...

$ 3000

Live Chat Support
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

> Live Chat
Live Chat by Comm100